Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 3270 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 7990 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 11250 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 14019 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 19879 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 45233 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 46227 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 49106 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 61486 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 114025 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 121373 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 128595 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 178393 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | PALMITIC ACID (M-H)- | 336483 | Peak area normalized | female | normoglycemic | Neuropathy |